Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | MGAM | O43451 | 2/20 | 0.38 |
| ▸ | SI | P14410 | 2/20 | 0.38 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.38 |
| ▸ | AKT1 | P31749 | 5/20 | 0.35 |
| ▸ | AKT2 | P31751 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3172557 | 0.90 | AKT1 (0.38) | GAAMGAMSIMGAM2AKT1 | |
| SCHEMBL1869206 | 0.84 | MGAM (0.35) | GAAMGAMSIMGAM2AKT1 | |
| SCHEMBL1872047 | 0.81 | MGAM (0.40) | GAAMGAMSIMGAM2AKT1 | |
| SCHEMBL1061886 | 0.80 | MAPT (0.43) | GAAAKT1AKT2KDM4E | |
| SCHEMBL16746558 | 0.79 | AKT1 (0.36) | GAAAKT1AKT2KDM4E | |
| SCHEMBL6693283 | 0.79 | GAA (0.33) | GAAMGAMSIMGAM2AKT1 | |
| SCHEMBL1868436 | 0.79 | FABP4 (0.33) | GAAMGAMSIMGAM2AKT1 | |
| SCHEMBL1864926 | 0.79 | AKT1 (0.35) | GAAMGAMSIMGAM2AKT1 | |
| SCHEMBL31734206 | 0.78 | MGAM (0.41) | GAAMGAMSIMGAM2AKT1 | |
| SCHEMBL1060924 | 0.78 | MGAM (0.36) | GAAMGAMSIMGAM2AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932300-B2 | Energy beam curable type ink jet printing ink | JSR CORPORATION (JP) | 2011-04-26 | — | — | US | claimed |
| US-6120973-A | PHOTOSENSITIVE COMPOSITION AND COLORS WITH POLYMERS | JSR CORPORATION (JP) | 2000-09-19 | — | — | US | claimed |
| US-6087050-A | Radiation sensitive composition and color filter | JSR CORPORATION (JP) | 2000-07-11 | — | — | US | claimed |
| EP-0902327-A2 | Radiation sensitive composition | JSR Corporation (JP) | 1999-03-17 | — | — | EP | claimed |
| EP-0881541-A1 | Radiation sensitive composition and color filter | JSR Corporation (JP) | 1998-12-02 | — | — | EP | claimed |
| EP-0875788-A1 | Radiation sensitive composition for color filters | JSR Corporation (JP) | 1998-11-04 | — | — | EP | claimed |
| WO-2026100662-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026100726-A1 | DECORATIVE FILM, ELECTRONIC MEMBER, AND TOUCH PAD | JSR株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-12577432-B2 | Organosilicon compound, production method therefor, and curable composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-4282653-B1 | ORGANOSILICON COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION | SHINETSU CHEMICAL CO (JP) | 2026-02-25 | — | — | EP | disclosed |
| US-12522684-B2 | Active-energy-ray-curable resin composition and cured product thereof | NIPPON SHOKUBAI CO., LTD. (JP) | 2026-01-13 | — | — | US | disclosed |
| EP-4159779-B1 | ACTIVE-ENERGY-RAY-CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF | NIPPON CATALYTIC CHEM IND (JP) | 2025-12-10 | — | — | EP | disclosed |
| WO-2025127098-A1 | PHASE DIFFERENCE FILM COMPOSITION AND SINGLE-LAYER PHASE DIFFERENCE MATERIAL | 日産化学株式会社 | 2025-06-19 | — | — | WO | disclosed |
| US-6087050-A | Radiation sensitive composition and color filter | JSR CORPORATION (JP) | 2000-07-11 | — | — | US | disclosed |
| US-6013415-A | Radiation sensitive composition | JSR CORPORATION (JP) | 2000-01-11 | — | — | US | disclosed |
| EP-0902327-A2 | Radiation sensitive composition | JSR Corporation (JP) | 1999-03-17 | — | — | EP | disclosed |
| EP-0893737-A2 | Radiation sensitive composition | JSR Corporation (JP) | 1999-01-27 | — | — | EP | disclosed |
| EP-0881541-A1 | Radiation sensitive composition and color filter | JSR Corporation (JP) | 1998-12-02 | — | — | EP | disclosed |
| EP-0875788-A1 | Radiation sensitive composition for color filters | JSR Corporation (JP) | 1998-11-04 | — | — | EP | disclosed |
| EP-0866367-A2 | Radiation sensitive composition | JSR Corporation (JP) | 1998-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577432-B2 | Organosilicon compound, production method therefor, and curable composition | ASH2L, DOT1L, DNMT3L | GAA 1531/4885MGAM 2341/4885SI 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.